Moderna announced on Friday its intention to develop a specific booster dose for the new Omicron variant of Covid-19, detected in South Africa and deemed "of concern" by the WHO.
"Moderna will rapidly develop a vaccine candidate for a booster dose specific to the Omicron variant," the US company said in a statement.
Coronavirus: The new variant called Omicron and classified as "worrying" by the WHO
Coronavirus: Canada, United States ... They are also closing their borders to travelers from southern African countries
Share on Messenger
Share on Facebook
Share on twitter
Share on Flipboard
Share on Pinterest
Share on Linkedin
Send by Mail
A fault ?